Showing 121 - 140 results of 173 for search '"movement disorder"', query time: 0.05s Refine Results
  1. 121

    Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy by Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda Chumki, Zvi Loewy

    Published 2016-01-01
    “…Cannabis and related compounds have created significant research interest as a promising therapy in neurodegenerative and movement disorders. In this review we examine the potential benefits of medical marijuana and related compounds in the treatment of both motor and nonmotor symptoms as well as in slowing the progression of the disease. …”
    Get full text
    Article
  2. 122

    Generation of an induced pluripotent stem cell line (UCLi026-A) from a patient with ADCY5-related disease carrying the heterozygous variant c.1253G > A; (p. Arg418Gln) by Sharmin Alhaque, Dimitri Budinger, Barbara Garavaglia, Giovanna Zorzi, Serena Barral, Manju A. Kurian

    Published 2025-04-01
    “…Heterozygous mutations in ADCY5 lead to ADCY5-related dyskinesia, comprising a wide array of disabling hyperkinetic movement disorders including chorea, myoclonus and/or dystonia. …”
    Get full text
    Article
  3. 123
  4. 124
  5. 125

    The Future of Research in Tourette Syndrome by Andrea E. Cavanna, Conor Kavanagh, Mary M. Robertson

    Published 2013-01-01
    “…Although there has been a paucity of research on TS compared to other movement disorders, in recent years TS has garnered increasing interest and has shown a number of novel and complex sides, about which much is yet to be learnt. …”
    Get full text
    Article
  6. 126
  7. 127

    Anti-N-Methyl-D-Aspartate Encephalitis as Paraneoplastic Manifestation of Germ-Cells Tumours: A Cases Report and Literature Review by Claudia Geraldine Rita, Israel Nieto Gañan, Adriano Jimenez Escrig, Ángela Carrasco Sayalero

    Published 2019-01-01
    “…There is a wide spectrum of clinical features starting by a viral-like prodrome, followed by symptoms such as psychosis, aggressive behaviour, memory loss, seizures, movement disorders, and autonomic instability. Up to 50% of the affected young female patients have germ-cells tumours as ovarian teratoma, making it essential to establish an early diagnosis through detection of specific antibodies in serum and cerebrospinal fluid (CSF). …”
    Get full text
    Article
  8. 128

    Gaitmap—An Open Ecosystem for IMU-Based Human Gait Analysis and Algorithm Benchmarking by Arne Kuderle, Martin Ullrich, Nils Roth, Malte Ollenschlager, Alzhraa A. Ibrahim, Hamid Moradi, Robert Richer, Ann-Kristin Seifer, Matthias Zurl, Raul C. Simpetru, Liv Herzer, Dominik Prossel, Felix Kluge, Bjoern M. Eskofier

    Published 2024-01-01
    “…<italic>Goal:</italic> Gait analysis using inertial measurement units (IMUs) has emerged as a promising method for monitoring movement disorders. However, the lack of public data and easy-to-use open-source algorithms hinders method comparison and clinical application development. …”
    Get full text
    Article
  9. 129
  10. 130

    Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson’s Disease Patients by D. Rada, J. Seco, E. Echevarría, B. Tijero, L. C. Abecia, J. C. Gómez-Esteban

    Published 2016-01-01
    “…An observational cross-sectional study was carried out using 105 Parkinson’s disease (PD) patients of the Movement Disorders Unit, Hospital de Cruces (Bilbao, Spain) [men 59 (56.2%), women 46 (43.85%)]. …”
    Get full text
    Article
  11. 131
  12. 132

    Thyroid-Induced Worsening of Parkinsonian Tremor Resistant to Drugs and Subthalamic Nucleus Deep Brain Stimulation by Michal Minár, Peter Valkovič

    Published 2014-01-01
    “…A hyperthyroid state can markedly exaggerate all forms of tremor, as well as other types of movement disorders. This condition can be overlooked or masked by other symptoms. …”
    Get full text
    Article
  13. 133

    Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease by Khashayar Dashtipour, Manju Liu, Camellia Kani, Pejman Dalaie, Andre Obenaus, Daniel Simmons, Nicole M. Gatto, Mehran Zarifi

    Published 2015-01-01
    “…Twelve de novo patients with PD were recruited from the Movement Disorders Clinic, Department of Neurology, Loma Linda University. …”
    Get full text
    Article
  14. 134

    A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset by Ján Necpál, Martin Stelzer, Silvia Koščová, Michal Patarák

    Published 2016-01-01
    “…Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized by rapidly progressive dementia along with various neurological features, including myoclonus and sometimes other movement disorders. The clinical course is typically insidious and rapid, leading to an early death. …”
    Get full text
    Article
  15. 135
  16. 136
  17. 137

    Early Infantile Epileptic Encephalopathy in an STXBP1 Patient with Lactic Acidemia and Normal Mitochondrial Respiratory Chain Function by Dong Li, Elizabeth Bhoj, Elizabeth McCormick, Fengxiang Wang, James Snyder, Tiancheng Wang, Yan Zhao, Cecilia Kim, Rosetta Chiavacci, Lifeng Tian, Marni J. Falk, Hakon Hakonarson

    Published 2016-01-01
    “…A wide range of clinical findings have been associated with mutations in Syntaxin Binding Protein 1 (STXBP1), including multiple forms of epilepsy, nonsyndromic intellectual disability, and movement disorders. STXBP1 mutations have recently been associated with mitochondrial pathology, although it remains unclear if this phenotype is a part of the core feature for this gene disorder. …”
    Get full text
    Article
  18. 138

    Neuromodulation: clinical advances and future perspectives by ZHANG Jian⁃guo, XIE Hu⁃tao, YANG An⁃chao

    Published 2025-01-01
    “…It analyzes their efficacy and potential in the fields of movement disorders, epilepsy, pain, cognitive impairment, and neurorehabilitation. …”
    Get full text
    Article
  19. 139

    Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes by Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye

    Published 2022-06-01
    “…It causes significant morbidity and disability through a plethora of symptoms, including movement disorders, sleep disturbances, and cognitive and psychiatric symptoms. …”
    Get full text
    Article
  20. 140